Elsevier Launches Biofuel Research and Discovery Tool, Accelerating BioEnergy Research and Development

NEW YORK, July 21, 2011 -

New Tool Enables
the Successful Commercialisation of
Alternative Energy Technologies

Elsevier, the world-leading provider of scientific, technical
and medical information products and services, today announced the
launch of Elsevier
Biofuel, an online search and discovery tool that provides
biofuel managers and research development professionals instant
access to the highest level of scientific, industrial, and
commercial information to solve their continued innovation
requirements. Through a wealth of content and information, Elsevier
Biofuel will assist companies in making key decisions surrounding
the Biofuel and the Bio-energy markets, making developments in the
industry quicker and more efficient.

“BioEnergy RD&D (Research, Development and Demonstration) is
a complex interdisciplinary challenge,” commented Marcus Gay,
Biofuels Information Consultant, Elsevier Biofuels. “As a former
BioEnergy R&D manager I am acutely aware of the technical,
economic and commercial challenges faced by professionals in the
industry. Elsevier’s Biofuel Information Discovery Tool pulls
together scientific and commercial information enabling researchers
to have this critical binocular vision during every stage of the
development process.”

The Elsevier Biofuel tool allows users to drill down to keywords
that pinpoint the exact information needed. Moreover, with the href="www.info.elsevier-biofuel.com/how_works.htm">Elsevier
Biofuel Tree Thesaurus (EBTT), research professionals can
easily and accurately navigate through more than 900 href="www.info.elsevier-biofuel.com/eb_journal_list.htm">journals
and 800 href="www.info.elsevier-biofuel.com/eb_book_list.htm">books,
5.8 million patent documents, enriched with 500,000 domain specific
keywords in the thesaurus and growing. The platform also allows
users to compare high-quality data specific to the biofuels
industry including:

• solve problems with existing scientific knowledge
• research new, promising advanced technologies 
• compare applicable approved pathways and
  methodologies 
• minimise waste in resources

“Having tested the beta version of Elsevier Biofuels discovery
tool thoroughly, it became immediately apparent how limiting the
information returned from internet only search is, by comparison”,
said Dr. Skye Thomas-Hall, Senior Scientist, href="cellana.com/">Cellana LLC, (a subsidiary of
Cellana, Inc. a Kona-headquartered developer of algae-based
biofuels and Bioproducts). “The combination of high quality
journal, book and patent information in one location, is a huge
advantage that increased my efficiency by at least 15-20%.”

About Elsevier Biofuels

Elsevier Biofuels online discovery platform was designed
specifically to help Biofuels R&D professionals find solutions
to R&D problems faster and support R&D investments
decisions. For further product information, please visit href="www.info.elsevier-biofuel.com">www.info.elsevier-biofuel.com

About Elsevier

Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in
partnership with the global science and health communities to
publish more than 2,000 journals, including href="www.thelancet.com">The Lancet and href="www.cell.com">Cell, and close to 20,000
book titles, including major reference works from Mosby and
Saunders. Elsevier’s online solutions include href="www.sciencedirect.com/">SciVerse ScienceDirect, href="www.scopus.com/">SciVerse Scopus, href="www.reaxys.com">Reaxys, href="www.mdconsult.com">MD Consult and href="www.nursingconsult.com">Nursing Consult, which
enhance the productivity of science and health professionals, and
the SciVal suite and href="www.medai.com">MEDai’s Pinpoint Review, which help
research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, href="www.elsevier.com">Elsevier employs 7,000 people
worldwide. The company is part of href="www.reedelsevier.com">Reed Elsevier Group PLC, a
world-leading publisher and information provider, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

Media Contact

Tom Reller
Vice President, Global Corporate Relations, Elsevier
href="mailto:T.Reller@elsevier.com">T.Reller@elsevier.com
+1-215-239-3508

.